Replies to post #130105 on Biotech Values

[exwannabe]

DNDN

They might not be close to being green but the drug is definately worth something and at these levels one would have to think they are a buyout candidate

Is it really clear it has value? It has been on the market for a year now and is bleeding hard.

But let us say that quality management can tighten it some and make a profit. How much?

Last Q the gross profits were about $10M. And that has to cover sales etc.

There is no buyout for north of $1B in the picture.